Clinical Trials Directory

Trials / Unknown

UnknownNCT01895010

Acupoint Electric Stimulation Combined With Tropisetron in Preventing and Treating Nausea and Vomiting After TACE

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
74 (estimated)
Sponsor
Fudan University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Observation on acupoint electric stimulation combined with tropisetron in preventing and treating nausea and vomiting and improving the patient's appetite after TACE for primary or metastatic liver cancer patients.

Detailed description

* Classification of nausea and vomiting, as measured by NCI CTC-AE version 3 * The improvement of appetite, as measure by the classification of Appetite in accordance with NCI CTC-AE version 3. * Quality of life: use M. D. Anderson symptom scale (the m. d. Anderson Symptom Inventory,MDASI)

Conditions

Interventions

TypeNameDescription
DEVICEacupoint electric stimulationacupoint electric stimulation combined with tropisetron 6mg before TACE
DRUGtropisetrononly tropisetron 6mg before TACE

Timeline

Start date
2013-06-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2013-07-10
Last updated
2013-07-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01895010. Inclusion in this directory is not an endorsement.

Acupoint Electric Stimulation Combined With Tropisetron in Preventing and Treating Nausea and Vomiting After TACE (NCT01895010) · Clinical Trials Directory